Cited by 176Glycosylation and Glycoproteins ResearchEnzyme Structure and FunctionCarbohydrate Chemistry and Synthesis

Crystal Structure of the Human Cytosolic Sialidase Neu2

Open access
Chavas, Leonard M.G., Tringali, Cristina, Fusi, Paola, Venerando, Bruno, Tettamanti, Guido, Kato, Ryuichi, Monti, Eugenio, Wakatsuki, Soichi·2005·Journal of Biological Chemistry

Abstract

Gangliosides play key roles in cell differentiation, cell-cell interactions, and transmembrane signaling. Sialidases hydrolyze sialic acids to produce asialo compounds, which is the first step of degradation processes of glycoproteins and gangliosides. Sialidase involvement has been implicated in some lysosomal storage disorders such as sialidosis and galactosialidosis. Neu2 is a recently identified human cytosolic sialidase. Here we report the first high resolution x-ray structures of mammalian sialidase, human Neu2, in its apo form and in complex with an inhibitor, 2-deoxy-2,3-dehydro-N-acetylneuraminic acid (DANA). The structure shows the canonical six-blade beta-propeller observed in viral and bacterial sialidases with its active site in a shallow crevice. In the complex structure, the inhibitor lies in the catalytic crevice surrounded by ten amino acids. In particular, the arginine triad, conserved among sialidases, aids in the proper positioning of the carboxylate group of DANA within the active site region. The tyrosine residue, Tyr(334), conserved among mammalian and bacterial sialidases as well as in viral neuraminidases, facilitates the enzymatic reaction by stabilizing a putative carbonium ion in the transition state. The loops containing Glu(111) and the catalytic aspartate Asp(46) are disordered in the apo form but upon binding of DANA become ordered to adopt two short alpha-helices to cover the inhibitor, illustrating the dynamic nature of substrate recognition. The N-acetyl and glycerol moieties of DANA are recognized by Neu2 residues not shared by bacterial sialidases and viral neuraminidases, which can be regarded as a key structural difference for potential drug design against bacteria, influenza, and other viruses.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1074/jbc.m411506200

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In NEU2, Asp97 is found on a loop that is disordered in the apo protein but points into the active site upon substrate binding.

    “In NEU2, Asp97 is found on a loop that is disordered in the apo protein but points into the active site upon substrate binding (11).”

    From Structure of the immunoregulatory sialidase NEU1 (2023) · cites this paper as [11]

    The Neu2-DANA Complex Structure passage (page unavailable) reports that two loops disordered in apo Neu2 become ordered upon inhibitor binding and cover the active site. It identifies Asp46, not Asp97, as the aspartate on one of those loops that moves close to the bound inhibitor. A search for Asp97 found no passage assigning it this role. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • The murine NEU1 crystal structure is most similar to that of human NEU2 and, to a lesser extent, to the Aspergillus fumigatus sialidase.

    “the murine NEU1 crystal structure is most similar to that of human NEU2 (fig. S1A) (11) and, to a lesser extent, to the Aspergillus fumigatus sialidase (67).”

    From Structure of the immunoregulatory sialidase NEU1 (2023) · cites this paper as [11]

  • Comparison to human NEU2-DANA confirms that the positions and orientations of the catalytic residues are conserved in NEU1, with the important exception of Asp97.

    “a comparison to the structure of human NEU2 in complex with the sialate-like inhibitor 2-deoxy-2,3-dehydro-N-acetylneuraminic acid (DANA) (11) confirms that the positions and orientations of all these residues are conserved in NEU1 (Fig. 2A), with the important exception of Asp97.”

    From Structure of the immunoregulatory sialidase NEU1 (2023) · cites this paper as [11]

  • The catalytic loop transitions from disordered to ordered upon substrate binding to NEU2, but in other eukaryotic sialidases of the GH33 family, this loop is productively positioned even without substrate.

    “The corresponding loop transitions from disordered to ordered upon substrate binding to NEU2 (11), but in other eukaryotic sialidases of the GH33 family, this loop is productively positioned even without substrate (65–68).”

    From Structure of the immunoregulatory sialidase NEU1 (2023) · cites this paper as [11]

  • Residues responsible for catalysis and stabilization of the sialate carboxyl group are conserved across the sialidase superfamily, while amino acids interacting with the N-acetyl and glycerol moieties are divergent.

    “Although the residues responsible for catalysis and stabilization of the sialate carboxyl group are conserved across the sialidase superfamily, amino acids that interact with the opposite side of the substrate, namely, its N-acetyl and glycerol moieties (Fig. 1B), are divergent (11).”

    From Structure of the immunoregulatory sialidase NEU1 (2023) · cites this paper as [11]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

No references could be resolved yet.

Research works printed but not linked: 26

  1. [1]1. Saito, M. ∙ Yu, R.K. Rosenberg, A. (Editor) Biology of the Sialic Acids Plenum Press, New York, 1995; 261-313 Crossref Google Scholar
  2. [2]2. Schauer, R. ∙ Kelm, S. ∙ Reuter, G. ... Rosenberg, A. (Editor) Biology of the Sialic Acids Plenum Press, New York, 1995; 7-67 Crossref Google Scholar
  3. [3]3. Monti, E. ∙ Bassi, M.T. ∙ Bresciani, R. ... Genomics. 2004; 83:445-453 Crossref Scopus (100) PubMed Google Scholar
  4. [4]4. Akita, H. ∙ Miyagi, T. ∙ Hata, K. ... Histochem. Cell Biol. 1997; 107:495-503 Crossref Scopus (24) PubMed Google Scholar
  5. [5]5. Sweeley, C.C. Adv. Lipid Res. 1993; 26:235-252 PubMed Google Scholar
  6. [6]6. Warner, T.G. ∙ Chang, J. ∙ Ferrari, J. ... Glycobiology. 1993; 3:455-463 Crossref Scopus (56) PubMed Google Scholar
  7. [7]7. Gramer, M.J. ∙ Goochee, C.F. ∙ Chock, V.Y. ... Biotechnology. 1995; 13:692-698 Crossref Scopus (91) PubMed Google Scholar
  8. [8]8. Monti, E. ∙ Preti, A. ∙ Rossi, E. ... Genomics. 1999; 57:137-143 Crossref Scopus (92) PubMed Google Scholar
  9. [9]9. Sato, K. ∙ Miyagi, T. Biochem. Biophys. Res. Commun. 1996; 221:826-830 Crossref Scopus (66) PubMed Google Scholar
  10. [10]10. Fanzani, A. ∙ Giuliani, R. ∙ Colombo, F. ... FEBS Lett. 2003; 547:183-188 Crossref Scopus (56) PubMed Google Scholar
  11. [11]11. Tokuyama, S. ∙ Moriya, S. ∙ Taniguchi, S. ... Int. J. Cancer. 1997; 73:410-415 Crossref Scopus (59) PubMed Google Scholar
  12. [12]12. Chan, K.F. ∙ Liu, Y. Glycobiology. 1991; 1:193-203 Crossref Scopus (29) PubMed Google Scholar
  13. [13]13. Gillard, B.K. ∙ Thurmon, L.T. ∙ Marcus, D.M. Glycobiology. 1993; 3:57-67 Crossref Scopus (75) PubMed Google Scholar
  14. [14]14. Sawada, M. ∙ Moriya, S. ∙ Saito, S. ... Int. J. Cancer. 2002; 97:180-185 Crossref Scopus (78) PubMed Google Scholar
  15. [15]15. Tringali, C. ∙ Papini, N. ∙ Fusi, P. ... J. Biol. Chem. 2004; 279:3169-3179 Full Text Full Text (PDF) Scopus (75) PubMed Google Scholar
  16. [16]16. Otwinowski, Z. ∙ Minor, W. Methods Enzymol. 1997; 276:307-326 Crossref Scopus (39110) PubMed Google Scholar
  17. [17]17. Potterton, E. ∙ Briggs, P. ∙ Turkenburg, M. ... Acta Crystallogr. Sect. D Biol. Crystallogr. 2003; 59:1131-1137 Crossref Scopus (1131) PubMed Google Scholar
  18. [18]18. Brünger, A.T. ∙ Adams, P.D. ∙ Clore, G.M. ... Acta Crystallogr. Sect. D Biol. Crystallogr. 1998; 54:905-921 Crossref Scopus (17070) PubMed Google Scholar
  19. [19]19. Perrakis, A. ∙ Morris, R. ∙ Lamzin, V.S. Nat. Struct. Biol. 1999; 6:458-463 Crossref Scopus (2577) PubMed Google Scholar
  20. [20]20. Jones, T.A. ∙ Zou, J.Y. ∙ Cowan, S.W. ... Acta Crystallogr. Sect. A. 1991; 47:110-119 Crossref Scopus (13097) PubMed Google Scholar
  21. [22]22. Kraulis, P.J. J. Appl. Crystallogr. 1991; 24:946-950 Crossref Google Scholar
  22. [23]23. Nicholls, A. ∙ Sharp, K. ∙ Honig, B. Proteins Struct. Funct. Genet. 1991; 11:281-296 Crossref Scopus (5340) PubMed Google Scholar
  23. [25]25. Wallace, A.C. ∙ Laskowski, R.A. ∙ Thornton, J.M. Protein Eng. 1995; 8:127-134 Crossref Scopus (4824) PubMed Google Scholar
  24. [26]26. Taylor, G. Curr. Opin. Struct. Biol. 1996; 6:830-837 Crossref Scopus (218) PubMed Google Scholar
  25. [27]27. Roggentin, P. ∙ Rothe, B. ∙ Kaper, J.B. ... Glycoconj. J. 1989; 6:349-353 Crossref Scopus (165) PubMed Google Scholar
  26. [28]28. Burmeister, W.P. ∙ Henrissat, B. ∙ Bosso, C. ... Structure (Lond.). 1993; 1:19-26

Cited by

Sorted by citations

Authors
Chavas, L. M. G., Tringali, C., Fusi, P., Venerando, B., Tettamanti, G., Kato, R., Monti, E., & Wakatsuki, S.
Affiliations
  • High Energy Accelerator Research Organization (JP)
  • University of Milan (IT)
  • University of Milano-Bicocca (IT)
  • The Graduate University for Advanced Studies, SOKENDAI (JP)
  • University of Brescia (IT)
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2005-01
Volume
280
Issue
1
Pages
469-475
ISSN
0021-9258 (ISSN-L)
OpenAlex
W1969846931
Cited by
176
References
0
Citations by year
2026: 4 · 2025: 8 · 2024: 6 · 2023: 5 · 2022: 6 · 2021: 7 · 2020: 8 · 2018: 8 · 2017: 8 · 2016: 5 · 2015: 7 · 2014: 11 · 2013: 11 · 2012: 15
FWCI
1.54
Type
journal article
Language
en
Open access
Locations
  • Journal of Biological Chemistry (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • BOA (University of Milano-Bicocca) (submittedVersion)
  • Institutional Repositories DataBase (IRDB) (submittedVersion)
  • Institutional Research Information System (Università degli Studi di Brescia) (submittedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
  • Physical Sciences › Materials Science › Materials Chemistry › Enzyme Structure and Function
  • Physical Sciences › Chemistry › Organic Chemistry › Carbohydrate Chemistry and Synthesis
Keywords
NEU2, neuraminidase, gangliosides, sialic acid hydrolysis, six-bladed β-propeller, catalytic aspartate, substrate recognition, glycoprotein degradation, lysosomal storage disease, sialidosis, galactosialidosis, inhibitor binding
MeSH terms
Animals, Humans, Models, Molecular, Neuraminidase, Structure-Activity Relationship, Substrate Specificity, Molecular Structure, Protein Structure, Secondary, Crystallography, X-Ray, N-Acetylneuraminic Acid, Catalytic Domain, Static Electricity

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review